MarketResearch.Biz delivers in-depth insights in its upcoming report titled “Global Molecular Imaging Devices Market: Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global molecular imaging devices market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the global molecular imaging devices market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. The report offers insightful and detailed information regarding the various key players operating in the global molecular imaging devices market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global molecular imaging devices market report has been segmented on the basis of techniques, applications and region.
Molecular imaging is a biomedical discipline that provides detailed visualizations and measurement of biologic processes taking place inside the body at molecular, cellular, and genetic level. Molecular imaging technique is used to detect and understand disease complexities in a more efficient manner, by finding abnormalities and malfunctioning areas in an individual.
Various techniques that have been used in molecular imaging includes Magnetic Resonance Imaging (MRI), Magnetic Resonance Spectroscopy (MRS), X-ray Computed Tomography (CT), ultrasound, optical imaging, single photon emission computed tomography (SPECT) and various others. Amongst all other techniques, photon emission tomography (PET) and SPCET are most widely used due to their ability to allow interrogation at detailed tissue depths. PET and SPCET scanners generate images of the lung, liver, and heart, and also provide information about an organ’s metabolism and other functions.
High incidence of cancer and cardiovascular diseases and increasing demand for accurate and efficient imaging systems for detection of abnormalities in the human body are key factors driving growth of the global molecular imaging devices market. Technological advancements in the fields of nanotechnology and robotics, increasing aging population, and rising adoption of hybrid imaging technologies are major factors driving growth of global molecular imaging devices market. In addition, this trend is expected to continue over the forecast period.
However, high cost of molecular imaging devices is a key restraint for growth of the global molecular imaging devices market currently. In addition, high product development costs, brand loyalty, and competitive pricing are major factors expected to hamper growth of global molecular imaging devices market to a certain extent over the forecast period.
Entry into the global molecular imaging devices market is restricted to new entrants, owing to high demand for complex technologies and strong financials to procure required equipment and systems. As a result, major trends witnessed in the global molecular imaging devices market are mergers and acquisitions, and licensing deals between major players.
North America dominated the global molecular imaging devices market in terms of revenue share, owing to high level of adoption of imaging devices in the healthcare industry. Europe accounted for second largest market share contribution to the global molecular imaging devices market, followed by Asia Pacific. Markets in emerging economies in Asia Pacific such as India and China are anticipated to expand at the highest CAGR of X.X% over the forecast period, due to rise in competitive business and easy availability of appropriate infrastructure in this region.
Global molecular imaging devices market segmentation by technique:
Global molecular imaging devices market segmentation by application:
- Cardio Vascular
Global molecular imaging devices market segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2016 Estimated Year 2017 Forecast Period 2017–2026 Revenue in US$
- GE Healthcare Affibody
- Hamamatsu Photonics
- Naviscanand Kereos
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!